Back to Search
DAVID TRUMP, M.D., M.P.H.
M.D., M.P.H.
Public Health & General Preventive Medicine Physician
NPI: 1982792347Individual
Specialties, Licenses & Credentials
Public Health & General Preventive Medicine PhysicianPrimary
Preventive Medicine — Public Health & General Preventive Medicine
Code: 2083P0901X
0101059228(VA)
Research & Publications (20)
Androgen antagonists: Potential role in prostate cancer prevention.
PMID 11295597·Urology·2001
8-other
Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy.
PMID 19517476·Cancer·2009
8-other
Phase II study of Dutasteride for recurrent prostate cancer during androgen deprivation therapy.
PMID 19091347·J Urol·2009
3-trial
Differential regulation of elastic fiber formation by fibulin-4 and -5.
PMID 19570982·J Biol Chem·2009
8-other
Retinoschisin, a new binding partner for L-type voltage-gated calcium channels in the retina.
PMID 19074145·J Biol Chem·2009
7-preclinical
Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.
PMID 19141646·Cancer Res·2009
7-preclinical
A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors.
PMID 19396601·Cancer Chemother Pharmacol·2009
3-trial
Vitamin D deficiency and insufficiency among patients with prostate cancer.
PMID 19426195·BJU Int·2009
8-other
Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer.
PMID 18830610·Int J Colorectal Dis·2009
8-other
Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis.
PMID 18285426·J Med Genet·2008
8-other
Phase II study of fulvestrant (Faslodex) in castration resistant prostate cancer.
PMID 18618738·Prostate·2008
3-trial
Skeletal health after continuation, withdrawal, or delay of alendronate in men with prostate cancer undergoing androgen-deprivation therapy.
PMID 18802155·J Clin Oncol·2008
2-rct
Using fluorodeoxythymidine to monitor anti-EGFR inhibitor therapy in squamous cell carcinoma xenografts.
PMID 18286491·Head Neck·2008
7-preclinical
Correlations between clinical and physiological consequences of the novel mutation R878C in a highly conserved pore residue in the cardiac Na+ channel.
PMID 18616619·Acta Physiol (Oxf)·2008
7-preclinical
Phenotype-specific CpG island methylation events in a murine model of prostate cancer.
PMID 18519676·Cancer Res·2008
7-preclinical
Circadian regulation of retinoschisin in the chick retina.
PMID 18385082·Invest Ophthalmol Vis Sci·2008
7-preclinical
A dramatic, objective antiandrogen withdrawal response: case report and review of the literature.
PMID 18986533·J Hematol Oncol·2008
5-case
1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model.
PMID 18790784·Mol Cancer Ther·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 416 J CLYDE MORRIS BLVD
NEWPORT NEWS, VA 23601 - Phone
- (757) 594-7305
Quick Facts
- NPI
- 1982792347
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile